Diabetes Study at Washington U. Advances
Posted on: Saturday, 25 March 2006, 00:00 CST
ST. LOUIS - A transplant-free approach to curing Type 1 diabetes using medication has been reaffirmed in tests on mice, according to a Washington University study.
The study, published this week in the journal Science, shows that there is a period of time in mice after the onset of diabetes where drugs can stop the immune system from attacking all the insulin-producing cells in the pancreas.
"You have a window of time in humans, too," said Dr. Emil Unanue, the study's author and Washington University immunologist.
The study advances a transplant-free approach to curing Type 1 diabetes with a short and inexpensive drug treatment.
The research also rebuked Harvard University research from three years ago that said adding adult stem cell proteins from the spleen into the mouse pancreas could create new pancreatic cells.
Dr. Denise Faustman, author of the Harvard study in 2003, said she was excited about the research advancing.
She said introducing spleen cells could have provided the protein that helps kill T-cells and not created a new source pancreatic cells, as her study suggested.
As many as 3 million diabetes cases are Type 1, according to the Juvenile Diabetes Research Foundation.
Type 1 diabetes is commonly a juvenile disease where immune system T-cells kill insulin making pancreatic cells that control blood sugar levels.
Researchers hope medication can eliminate the need for pancreatic cell transplants that have been done on about 500 people and require long-term drug treatment.
Source: Associated Press/AP Online
Related Articles
- Cryo-Cell Announces C'elle(SM) Research and Development Collaboration for Chronic Wound Healing Management
- Vitro Diagnostics Wins Approval for Diabetes Study Protocol
- Vitro Receives Approval for Preclinical Diabetes Study Protocol
- Death Risk Halts Diabetes Study
- WunderMarx Launches Web Site for UC Irvine Center for Diabetes Treatment and Research
- Tissera Reports Encouraging Preliminary Results of Its Large Animal Diabetic Model Experiments of Pancreatic Xenotransplantation
- Diabetes Study Called Partial Success
- New Study From Ball State University Says Average Person Spends More Time Using Media Than Anything Else
- Lisofylline in Combination With Exendin-4 Reverses Diabetes in a Type 1 Model; LSF and GLP-1 Treatment Also Improved Islet Cell Viability and Normalized Insulin Secretion
- The CARDS Investigators: Primary Prevention of Cardiovascular Disease With Atorvastatin in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre Randomised Placebo- Controlled Trial
User Comments (0)

RSS Feeds